Justera Health Ltd.
SCRSF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.00 | -0.06 |
| FCF Yield | 420.97% | -89.28% | -37.28% | -10.00% |
| EV / EBITDA | -0.71 | -0.21 | -7.84 | -5.32 |
| Quality | ||||
| ROIC | 11.86% | 55.49% | 19.90% | 101.92% |
| Gross Margin | 100.00% | 55.65% | 68.07% | 63.51% |
| Cash Conversion Ratio | -1.19 | 0.05 | 0.39 | 0.80 |
| Growth | ||||
| Revenue 3-Year CAGR | -54.10% | -49.50% | -50.29% | -55.90% |
| Free Cash Flow Growth | 500.07% | -965.82% | 83.25% | 85.83% |
| Safety | ||||
| Net Debt / EBITDA | -0.29 | -0.10 | -6.43 | -0.95 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 2.04 | 1.59 | 1.88 |
| Cash Conversion Cycle | 11,140.18 | -1,481.62 | -864.25 | -692.70 |